Dibenzo[b,d]thiophene-4,6-diboronic acid | CAS:1266231-16-2

We serve Dibenzo[b,d]thiophene-4,6-diboronic acid CAS:1266231-16-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Dibenzo[b,d]thiophene-4,6-diboronic acid

Chemical Name:Dibenzo[b,d]thiophene-4,6-diboronic acid
CAS.NO:1266231-16-2
Synonyms:Dibenzo[b,d]thiophene-4,6-diboronic acid
Molecular Formula:C12H10B2O4S
Molecular Weight:271.8924
 
Specification:
Appearance:White powder
Assay:≥99.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:OLED intermediates



Contact us for information like Dibenzo[b,d]thiophene-4,6-diboronic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Dibenzo[b,d]thiophene-4,6-diboronic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Dibenzo[b,d]thiophene-4,6-diboronic acid Use and application,Dibenzo[b,d]thiophene-4,6-diboronic acid technical grade,usp/ep/jp grade.


Related News: Further research on Oligomannate’s pharmacological mechanism and long-term safety and effectiveness is required, according to the NMPA statement.dibenzofuran-2-ylboronic acid manufacturer United Airlines — which announced that it will suspend flights to Beijing, Chengdu and Shanghai from February 6 — is also reducing flights from the US to Hong Kong.2,3-Difluorophenyl butyl ether supplier United Airlines — which announced that it will suspend flights to Beijing, Chengdu and Shanghai from February 6 — is also reducing flights from the US to Hong Kong.Polysiloxanes di-Me Me hydrogen vendor The Breakthrough Designation for the iLet Bionic Pancreas System contemplates configurations with most insulin analogs approved for pumping as well as dasiglucagon, Zealand Pharma’s stable pumpable glucagon analog, which has a unique stability profile in a ready-to-use aqueous solution.The Breakthrough Designation for the iLet Bionic Pancreas System contemplates configurations with most insulin analogs approved for pumping as well as dasiglucagon, Zealand Pharma’s stable pumpable glucagon analog, which has a unique stability profile in a ready-to-use aqueous solution.